288 related articles for article (PubMed ID: 32669353)
1. α-Synuclein Induces Progressive Changes in Brain Microstructure and Sensory-Evoked Brain Function That Precedes Locomotor Decline.
Chu WT; DeSimone JC; Riffe CJ; Liu H; Chakrabarty P; Giasson BI; Vedam-Mai V; Vaillancourt DE
J Neurosci; 2020 Aug; 40(34):6649-6659. PubMed ID: 32669353
[No Abstract] [Full Text] [Related]
2. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.
Kulkarni AS; Del Mar Cortijo M; Roberts ER; Suggs TL; Stover HB; Pena-Bravo JI; Steiner JA; Luk KC; Brundin P; Wesson DW
J Parkinsons Dis; 2020; 10(4):1411-1427. PubMed ID: 32925105
[TBL] [Abstract][Full Text] [Related]
3. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
[TBL] [Abstract][Full Text] [Related]
5. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils.
Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P
J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164
[TBL] [Abstract][Full Text] [Related]
6. Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils.
Ayers JI; Brooks MM; Rutherford NJ; Howard JK; Sorrentino ZA; Riffe CJ; Giasson BI
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852849
[TBL] [Abstract][Full Text] [Related]
7. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
[TBL] [Abstract][Full Text] [Related]
8. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice.
Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK
J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
[TBL] [Abstract][Full Text] [Related]
11. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
12. Progression of phosphorylated α-synuclein in Macaca fuscata.
Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M
Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430
[TBL] [Abstract][Full Text] [Related]
13. Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy.
Wang XJ; Ma MM; Zhou LB; Jiang XY; Hao MM; Teng RKF; Wu E; Tang BS; Li JY; Teng JF; Ding XB
Nat Commun; 2020 Feb; 11(1):934. PubMed ID: 32071315
[TBL] [Abstract][Full Text] [Related]
14. Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein.
Howe JW; Sortwell CE; Duffy MF; Kemp CJ; Russell CP; Kubik M; Patel P; Luk KC; El-Agnaf OMA; Patterson JR
Parkinsonism Relat Disord; 2021 Aug; 89():41-47. PubMed ID: 34218047
[TBL] [Abstract][Full Text] [Related]
15. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
[TBL] [Abstract][Full Text] [Related]
16. GV-971 attenuates α-Synuclein aggregation and related pathology.
Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
[TBL] [Abstract][Full Text] [Related]
17. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain.
Ferreira N; Gonçalves NP; Jan A; Jensen NM; van der Laan A; Mohseni S; Vægter CB; Jensen PH
Acta Neuropathol Commun; 2021 Feb; 9(1):31. PubMed ID: 33632316
[TBL] [Abstract][Full Text] [Related]
18. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice.
Luk KC; Kehm VM; Zhang B; O'Brien P; Trojanowski JQ; Lee VM
J Exp Med; 2012 May; 209(5):975-86. PubMed ID: 22508839
[TBL] [Abstract][Full Text] [Related]
19. Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies.
Rockenstein E; Ostroff G; Dikengil F; Rus F; Mante M; Florio J; Adame A; Trinh I; Kim C; Overk C; Masliah E; Rissman RA
J Neurosci; 2018 Jan; 38(4):1000-1014. PubMed ID: 29246926
[TBL] [Abstract][Full Text] [Related]
20. [Animal models of synucleinopathies: prion-like propagation of alpha-synuclein in wild-type animals].
Masuda-Suzukake M
Nihon Yakurigaku Zasshi; 2019; 154(6):301-305. PubMed ID: 31787680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]